Race Oncology Ltd (ASX: RAC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Race Oncology Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $477.97 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 144.40 million
Earnings per share -0.037
Dividend per share N/A
Year To Date Return 92.00%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

Race Oncology Ltd (ASX: RAC)
Latest News

RAC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Race Oncology Ltd

Race Oncology Ltd is an Australian pharmaceutical company whose business model is to pursue and bring to market later stage assets, principally in the cancer field.

RAC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Aug 2021 $3.36 $0.04 1.20% 145,420 $3.35 $3.39 $3.32
02 Aug 2021 $3.32 $-0.03 -0.90% 122,839 $3.36 $3.41 $3.32
30 Jul 2021 $3.35 $-0.09 -2.62% 297,929 $3.44 $3.44 $3.33
29 Jul 2021 $3.44 $-0.10 -2.82% 480,035 $3.56 $3.57 $3.38
28 Jul 2021 $3.54 $-0.07 -1.94% 191,344 $3.62 $3.64 $3.54
27 Jul 2021 $3.61 $-0.02 -0.55% 128,609 $3.68 $3.70 $3.61
26 Jul 2021 $3.63 $-0.04 -1.09% 185,850 $3.69 $3.75 $3.63
23 Jul 2021 $3.67 $-0.03 -0.81% 205,794 $3.74 $3.74 $3.61
22 Jul 2021 $3.70 $-0.02 -0.54% 285,757 $3.75 $3.84 $3.69
21 Jul 2021 $3.72 $0.13 3.62% 435,174 $3.59 $3.80 $3.57
20 Jul 2021 $3.59 $0.08 2.28% 104,545 $3.56 $3.59 $3.53
19 Jul 2021 $3.51 $-0.02 -0.57% 284,660 $3.55 $3.61 $3.50
16 Jul 2021 $3.53 $-0.01 -0.28% 119,626 $3.52 $3.56 $3.49
15 Jul 2021 $3.54 $0.01 0.28% 143,324 $3.55 $3.57 $3.49
14 Jul 2021 $3.53 $-0.04 -1.12% 189,634 $3.51 $3.57 $3.48
13 Jul 2021 $3.57 $0.06 1.71% 185,668 $3.55 $3.59 $3.49
12 Jul 2021 $3.51 $0.00 0.00% 140,131 $3.50 $3.62 $3.50
09 Jul 2021 $3.51 $-0.07 -1.96% 207,780 $3.57 $3.57 $3.50
08 Jul 2021 $3.58 $0.01 0.28% 174,474 $3.58 $3.69 $3.57
07 Jul 2021 $3.57 $-0.03 -0.83% 216,092 $3.59 $3.62 $3.56
06 Jul 2021 $3.60 $0.00 0.00% 160,659 $3.61 $3.65 $3.59

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
28 Jun 2021 Mary Harney Buy 5 $20,118
On-market trade.
19 May 2021 Mary Harney Issued 400 $1,280
Issue of options.
19 May 2021 Daniel Tillett Issued 672 $2,152,000
Issue of options.
19 May 2021 Phillip(Phil) Lynch Issued 20 $67,065
Issue of options.
15 Mar 2021 Mary Harney Buy 8 $31,567
On-market trade.
10 Mar 2021 Daniel Tillett Buy 4 $420,750
Exercise of options.
10 Mar 2021 Daniel Tillett Exercise 4 $420,750
Exercise of options.
30 Nov 2020 Borje Andersson Issued 1 $3,328,000
Issue of options.
30 Nov 2020 Borje Andersson Issued 118 $246,640
Issue of securities. 118,577 - performance rights
30 Nov 2020 Phillip(Phil) Lynch Issued 2 $4,160,000
Issue of options.
30 Nov 2020 Daniel Tillett Issued 2 $4,160,000
Issue of options.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr John Cullity Executive ChairmanExecutive Director Apr 2018
Dr Cullity is Managing Director at BioSynergy Partners, a New York and Melbourne
based advisory recently spun out of Torreya - the renowned life sciences
investment bank. He additionally serves on the Boards of several life sciences
companies including Ceramedix (seeded by Torreya). He graduated in Medicine and carries experience in haematology-oncology.
Dr Daniel Tillett Chief Scientific OfficerExecutive Director Sep 2019
Dr Tillett is the CEO and founder of Nucleics Pty Ltd, a private biotechnology
company in the genomics space.
Mr Phillip(Phil) R Lynch Chief Executive OfficerManaging Director Jun 2020
Mr Lynch has over 15 years in commercial leadership with J&J companies, bringing M&A experience and strong relationships in Asia-Pacific
Ms Mary Harney Non-Executive Director Feb 2021
Ms Harney is a company director with commercial experience, based on multiple years developing assets in oncology and the healthcare landscape. Ms Harney has an understanding of academic and applied life science research, in addition to biopharmaceutical regulatory affairs and commercialization experience. Ms Harney is the director of specialist consulting firm - Mary Harney Advisory - providing leadership, governance and strategic advice across innovation industries such as health, biotech and agriculture. She currently also serves as Chairman of private Australian biotech, CTxONE Pty Ltd - a cancer drug discovery and development company pursuing novel epigenetic and immuno-oncology programs. She was formerly the CEO of Royal Australasian College of Surgeons; CEO of Gardiner Research Foundation; COO and Director of Office of Cancer Research for Peter MacCallum Hospital and COO of Cerylid Biosciences. Other former roles were with CSL, Amrad, BIOPROPERTIES and Royal Melbourne Hospital. In 2017, she completed 'Strategy in the Age of Digital Disruption' at INSEAD Business School.
Mr Peter Webse Company Secretary Aug 2016
-
Peter Webse Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Dr William James Garner 13,680,078 10.73%
Dr Daniel Tillett 9,200,000 7.21%
The Trust Company (Australia) Limited (Mof A/C) 9,154,765 7.18%
Mr Phillip Richard Perry 5,825,694 4.57%
Biosynergy Partners Pty Ltd 3,787,878 2.97%
Mr Mark Phillip Juan 1,548,958 1.21%
Mr Peter Laurence Molloy 1,525,378 1.20%
Mr Phillip Richard Perry & Mrs Tetyana Perry (Doneska Super Fund A/C) 1,490,000 1.17%
Mr Anthony James Robinson (The Peeko Family No 86 A/C) 1,436,665 1.13%
Mr John Andrew Rodgers (John Rodgers Family A/C) 1,428,570 1.12%
Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Dro) 1,421,587 1.11%
Moggs Creek Pty Ltd (Moggs Creek Super A/C) 1,255,892 0.98%
Citicorp Nominees Pty Limited 1,208,840 0.95%
Mr Andrew David Walker & Mrs Angela Rosemary Walker 1,156,000 0.91%
Mr Kenneth Barry Ridley & Mrs Catherine Mary Ridley (Ridley Retirement Fund A/C) 1,153,000 0.90%
Mr Kimberley Ross Gartrell & Mrs Jennifer Margaret Gartrell (K&J Gartrell Super Fund A/C) 1,085,000 0.85%
Ms Nicole Gallin & Mr Kyle Haynes (Gh Super Fund A/C) 950,000 0.74%
Mr Sandor Helby 912,880 0.72%
Mr Andrew Jacobs 823,746 0.65%
Mr Graeme Stewart Pocknall & Mrs Vivienne Glynis Pocknall 801,775 0.63%

Profile

since

Note